Brian Finn
Angel Investor · at Marstar Investments
New York, United States
Brian Finn is a seed investor at Marstar Investments in New York focused on Artificial Intelligence and Baby. Brian D. Finn is based out of New York, New York and is the Non-Executive Chairman of Star Mountain Capital. Brian previously worked at Asset Management Finance Corp as Chairman and Chief Executive Officer. Brian D. Finn attended the Wharton School of the University of Pennsylvania.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Brian Finn invests in
Stages Brian Finn invests in
Countries Brian Finn invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 2 (29%)
- Baby 1 (14%)
- SaaS 1 (14%)
- Sales 1 (14%)
- EdTech 1 (14%)
Stage
- Seed 3 (43%)
- Series A 1 (14%)
- Series C 1 (14%)
- Convertible Note 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Holistic Spirits develops a superfood plant-powered holistic gin and cocktails.Holistic Spirits offers Origen Holistic Spirits speciality vodka and Harmony Gin which is patent-pending, plant-powered, holistic spirits that elevates the experience of wellness with every cocktail, while caring for the earth.The company was founded in 2018 and isbased in Park City, Utah. | $1M / Seed / Sep 01, 2022 | ||
| Sarcos is a wearable and teleoperated industrial robotics company that augments humans to enhance productivity and safety.Sarcos Robotics augments human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Leveraging more than 30years of research and development, Sarcos’ mobile robotic systems, including the Guardian® S, Guardian® GT, and Guardian® XO®, are revolutionizing the future of work wherever physically demanding work is done. Formerly the robotics division of a major defense contractor, Sarcos is based in Salt Lake City, Utah, powered by an innovative team of entrepreneurs and engineers. | $40M / Series C / Sep 01, 2020 | ||
| VOIQ brings the power of AI Conversational Voice to every business website, web app, and mobile app on the planet. VOIQ's SaaS platform empowers companies to build highly-trained Conversational Voice Assistants for their website, web app and mobile app. Our Voice Assistants take on each brand's unique identity to engage and guideprospects, answer their questions, and convert them into customers. | $2M / Seed / Nov 05, 2019 | ||
| BabySparks is a developer of tools and programs to help parents engage their babies and toddlers in the critical areas of early development. The company's early development program learns each child's unique profile, identifies specific needs, and provides meaningful activities to support them.The company was established in 2013 and isheadquartered in Plantation, Florida. | $2M / Seed / Jan 15, 2019 | ||
| Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses. | $200K / Convertible Note / Jan 18, 2016 | ||
| Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses. | $200K / Convertible Note / May 14, 2015 | ||
| Estimize is an online crowdsourcing platform that shares and reviews fundamental financial estimates from independent, buy-side, and sell-side analysts, along with those of private investors and students. It acts as an online community and discussion forum for hedge funds and asset management professionals to interact and get a true view of marketexpectations. Estimize is also available on major financial research platforms such as Bloomberg, Quantopian, and more. The platform was launched in 2011 and its operations are based in New York, United States. | $1.2M / Series A / Mar 26, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Brian Finn invest in?
Brian Finn invests primarily in Artificial Intelligence, Baby and SaaS startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Brian Finn?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Brian Finn last invest?
The most recent investment recorded for Brian Finn closed in Sep 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
